Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 23142962)

1.

Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study.

Stokholm J, Teasdale TW, Johannsen P, Nielsen JE, Nielsen TT, Isaacs A, Brown JM, Gade A; Frontotemporal dementia Research in Jutland Association (FReJA) consortium.

J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):170-6. doi: 10.1136/jnnp-2012-303813. Epub 2012 Nov 10.

PMID:
23142962
2.

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, De Vita E, Masellis M, Black SE, Freedman M, Keren R, MacIntosh BJ, Rogaeva E, Tang-Wai D, Tartaglia MC, Laforce R Jr, Tagliavini F, Tiraboschi P, Redaelli V, Prioni S, Grisoli M, Borroni B, Padovani A, Galimberti D, Scarpini E, Arighi A, Fumagalli G, Rowe JB, Coyle-Gilchrist I, Graff C, Fallström M, Jelic V, Ståhlbom AK, Andersson C, Thonberg H, Lilius L, Frisoni GB, Pievani M, Bocchetta M, Benussi L, Ghidoni R, Finger E, Sorbi S, Nacmias B, Lombardi G, Polito C, Warren JD, Ourselin S, Fox NC, Rossor MN.

Lancet Neurol. 2015 Mar;14(3):253-62. doi: 10.1016/S1474-4422(14)70324-2. Epub 2015 Feb 4.

3.

Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.

Verny C, Allain P, Prudean A, Malinge MC, Gohier B, Scherer C, Bonneau D, Dubas F, Le Gall D.

Eur J Neurol. 2007 Dec;14(12):1344-50. Epub 2007 Oct 17.

PMID:
17941857
4.

Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.

Oh SI, Park A, Kim HJ, Oh KW, Choi H, Kwon MJ, Ki CS, Kim HT, Kim SH.

PLoS One. 2014 Feb 3;9(2):e87163. doi: 10.1371/journal.pone.0087163. eCollection 2014.

5.

Frontotemporal dementia caused by CHMP2B mutations.

Isaacs AM, Johannsen P, Holm I, Nielsen JE; FReJA consortium.

Curr Alzheimer Res. 2011 May;8(3):246-51. Review.

6.

Neuropsychological function in nondemented carriers of presenilin-1 mutations.

Ringman JM, Diaz-Olavarrieta C, Rodriguez Y, Chavez M, Fairbanks L, Paz F, Varpetian A, Maldonado HC, Macias-Islas MA, Murrell J, Ghetti B, Kawas C.

Neurology. 2005 Aug 23;65(4):552-8.

7.

Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene.

Holm IE, Isaacs AM, Mackenzie IR.

Acta Neuropathol. 2009 Nov;118(5):719-20. doi: 10.1007/s00401-009-0593-1. Epub 2009 Oct 21. No abstract available.

PMID:
19844732
8.

Neuropsychological features of asymptomatic c.709-1G>A progranulin mutation carriers.

Barandiaran M, Estanga A, Moreno F, Indakoetxea B, Alzualde A, Balluerka N, Martí Massó JF, López de Munain A.

J Int Neuropsychol Soc. 2012 Nov;18(6):1086-90. doi: 10.1017/S1355617712000823.

PMID:
23158232
9.

Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia.

Stopford CL, Thompson JC, Neary D, Richardson AM, Snowden JS.

Cortex. 2012 Apr;48(4):429-46. doi: 10.1016/j.cortex.2010.12.002. Epub 2010 Dec 21.

PMID:
21237452
10.

Early neuropsychological characteristics of progranulin mutation carriers.

Hallam BJ, Jacova C, Hsiung GY, Wittenberg D, Sengdy P, Bouchard-Kerr P, Slack P, Rademakers R, Baker M, Chow TW, Levine B, Feldman HH, Mackenzie IR.

J Int Neuropsychol Soc. 2014 Aug;20(7):694-703. doi: 10.1017/S1355617714000551. Epub 2014 Jul 4.

PMID:
24993774
11.

Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R.

J Neurol. 2004 Aug;251(8):935-42.

PMID:
15316797
12.

The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia.

Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M.

Am J Psychiatry. 2005 Nov;162(11):2078-85.

PMID:
16263847
13.

Executive functions in frontotemporal dementia and Lewy body dementia.

Johns EK, Phillips NA, Belleville S, Goupil D, Babins L, Kelner N, Ska B, Gilbert B, Inglis G, Panisset M, de Boysson C, Chertkow H.

Neuropsychology. 2009 Nov;23(6):765-77. doi: 10.1037/a0016792.

PMID:
19899835
14.

Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.

Urwin H, Authier A, Nielsen JE, Metcalf D, Powell C, Froud K, Malcolm DS, Holm I, Johannsen P, Brown J, Fisher EM, van der Zee J, Bruyland M; FReJA Consortium, Van Broeckhoven C, Collinge J, Brandner S, Futter C, Isaacs AM.

Hum Mol Genet. 2010 Jun 1;19(11):2228-38. doi: 10.1093/hmg/ddq100. Epub 2010 Mar 10.

15.

[DEX and executive dysfunction in activities of daily living in Alzheimer's disease and frontotemporal dementia].

Piquard A, Derouesné C, Meininger V, Lacomblez L.

Psychol Neuropsychiatr Vieil. 2010 Sep;8(3):215-24; quiz 225-7. doi: 10.1684/pnv.2010.0220. French.

PMID:
20739260
16.

The relationship between acquired impairments of executive function and behaviour change in adults with Down syndrome.

Adams D, Oliver C.

J Intellect Disabil Res. 2010 May;54(5):393-405. doi: 10.1111/j.1365-2788.2010.01271.x. Epub 2010 Mar 26.

PMID:
20367747
17.

Presymptomatic generalized brain atrophy in frontotemporal dementia caused by CHMP2B mutation.

Rohrer JD, Ahsan RL, Isaacs AM, Nielsen JE, Ostergaard L, Scahill R, Warren JD, Rossor MN, Fox NC, Johannsen P; FReJA consortium.

Dement Geriatr Cogn Disord. 2009;27(2):182-6. doi: 10.1159/000200466. Epub 2009 Feb 7.

PMID:
19202337
18.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
19.

CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia.

Rizzu P, van Mil SE, Anar B, Rosso SM, Donker Kaat L, Heutink P, van Swieten JC.

Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):944-6.

PMID:
16941655
20.

Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.

Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.

J Clin Psychiatry. 2009 Oct;70(10):1379-84. doi: 10.4088/JCP.08m04593. Epub 2009 Jun 30.

PMID:
19573495
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk